Growth Markets SSI has established a global footprint with installations in over 80 countries and main growth markets in China, the U.S., and the EU. Sales opportunities lie in expanding adoption of Aixplorer MACH series in these regions, particularly where ultrasound imaging demand and advanced elastography are expanding.

Clinical Advantage UltraFast technology and ShearWave Elastography provide non-invasive tissue stiffness analysis with strong clinical validation (600+ articles). Position this as a differentiator to win contracts in breast, liver, and prostate imaging segments, targeting hospitals and academic centers seeking cutting-edge elastography capabilities.

Product Roadmap Recent and historical product launches (Aixplorer MACH 30, premium Aixplorer Ultimate) indicate a continuing cadence of high-end systems. Identify opportunities to upsell from existing customers to newer models and to cross-sell upgraded transducers or software modes to enhance diagnostic throughput.

Strategic Partnerships Past events show acquisition activity and high-profile financial interest. Leverage potential partnerships, distribution deals, or co-marketing with regional distributors and medical groups, especially in markets where SSI has low penetration or where competitors dominate.

Regulatory Ready With CE and FDA clearances already in place and broad indication coverage, target large multi-site hospitals and imaging centers that require compliant, scalable ultrasound solutions. Emphasize reliability, service coverage, and training programs to reduce adoption risk and accelerate purchasing cycles.